Adam Mcananey Sells 9,859 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) insider Adam Mcananey sold 9,859 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider directly owned 218,096 shares in the company, valued at approximately $4,785,026.24. This represents a 4.32% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Price Performance

Oscar Health stock opened at $24.59 on Friday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11. The firm has a market cap of $7.41 billion, a P/E ratio of -41.68, a P/E/G ratio of 1.65 and a beta of 2.37. The business’s fifty day moving average is $18.39 and its two-hundred day moving average is $16.06. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $25.58.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. The company had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business’s revenue was up 52.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.92 earnings per share. Equities research analysts forecast that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Several large investors have recently made changes to their positions in OSCR. Jones Financial Companies Lllp lifted its stake in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio acquired a new position in shares of Oscar Health during the first quarter valued at $30,000. Fifth Third Bancorp increased its holdings in Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after purchasing an additional 1,413 shares during the last quarter. Quarry LP lifted its stake in Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares during the period. Finally, Tsfg LLC acquired a new position in Oscar Health in the third quarter valued at about $38,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Key Oscar Health News

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com
• Positive Sentiment: Oscar Health’s recent earnings showed a major EPS beat, which supports the stock’s fundamental story despite revenue coming in below estimates.
• Neutral Sentiment: A company co-founder shifting into an advisory leadership role looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role
• Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley and CAO Victoria Baltrus, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.
• Negative Sentiment: Director Mario Schlosser sold 34,120 shares, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.

Analyst Upgrades and Downgrades

OSCR has been the topic of several research reports. Robert W. Baird upped their price target on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Jefferies Financial Group raised Oscar Health from an “underperform” rating to a “hold” rating and upped their price target for the company from $10.00 to $16.00 in a research note on Monday, April 20th. Wells Fargo & Company set a $20.00 price target on Oscar Health and gave the company an “equal weight” rating in a research note on Thursday. Raymond James Financial raised Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target on the stock in a research note on Thursday, February 12th. Finally, Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $20.22.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.